Xanax and opioids: new study tests safety and abuse risk
NCT ID NCT06757140
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is testing how the drugs alprazolam (Xanax) and oxycodone (an opioid) interact when taken together. Researchers will give small, non-therapeutic doses to 25 healthy adults who already use these drugs. They will measure how much participants like the drug combination, any side effects, and how the drugs move through the body. The goal is to better understand the safety and abuse potential of mixing these medications.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- alprazolam (Xanax) and oxycodone (Percocet, Roxicodone)
- What this could lead to
- If successful, this could help doctors understand the risks of combining these drugs, leading to safer prescribing guidelines.
- What could go wrong
- This is an early-phase study with only 25 participants, so results may not apply to everyone. The drugs are given experimentally and may cause side effects like drowsiness or breathing problems.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Phase 1/2
Runs two stages together: safety and dose first, then whether the treatment works.
- Participants
-
About 25 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Apr 2025
- Expected to finish
-
Jun 2029
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 55 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * English-speaking and literate participants, able to understand and sign Informed Consent Document * ages 18 to 55 years old inclusive * BMI of greater than/equal to 17 and approximately less than or equal to 30 * self-reported opioid use * self-reported sedative-like drug use * women of childbearing potential must not be pregnant or breastfeeding at screening and be using an effective form of contraception throughout study participation * otherwise healthy as determined by the medical/research team based on medical history, physical examination, vital signs, laboratory chemistries (blood chemistry with liver function tests and hematology, urinalysis and microscopic evaluation, 12-lead electrocardiogram) * willing and able to comply with all testing requirements defined in the protocol * adequate venous access (determined by RN) for pharmacokinetic blood draws Exclusion Criteria: * physical dependence on alcohol, opioids, benzodiazepines or sedative/hypnotics requiring medical management/detoxification * seeking treatment for opioid or any other drug use * acute medical problem (e.g., infection) or chronic medical problem requiring daily medication or ongoing medical care (e.g., hypertension, cardiovascular disease, diabetes, respiratory disorders \[e.g., asthma, COPD\]) * clinically significant abnormal ECG (as determined by study physician/cardiologist) * clinically significant abnormal laboratory findings (e.g., liver function tests greater than 3x the upper limits of normal range) * current or past history of major psychiatric disorder that would limit ability to participate in the study (e.g., bipolar disorder). * recent use of CYP2C9, CYP2D6 and CYP3A4 inhibitor or inducer that is long-acting and not amenable to a wash-out period after enrollment * known hypersensitivity to any of the study drugs * currently pregnant or breastfeeding * currently under parole or probation with urine testing requirements
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Drug interactions are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
University of Kentucky
RECRUITINGLexington, Kentucky, 40508, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New shot may lower heart risk in patients whose medications block statins
- New Decision-Making tool aims to prevent bleeding in blood thinner users
- Heart Patients' hidden danger: risky drug mixes under the microscope
- Grapefruit juice could change how depression drug works
- Drug combo safety check: early study completed
- Can a simple online survey unlock the secrets to active longevity?